SYNM | bioCADDIE Data Discovery Index
Mountain View
biomedical and healthCAre Data Discovery Index Ecosystem
help Advanced Search
Displaying 20 of 311 results for "SYNM"
i
  1. DMD_CANLF UniProt:Swiss-Prot

    ID: O97592

    Description: ZZ-type ANK2- and ANK-3 binding Interaction with SYNM Interaction with SYNM Binds to SNTB1 Phosphoserine Phosphoserine Phosphoserine Phosphoserine Phosphoserine Phosphoserine Phosphoserine Phosphoserine Phosphoserine...

  2. DMD_PIG UniProt:Swiss-Prot

    ID: Q5GN48

    Description: ZZ-type ANK2- and ANK-3 binding Interaction with SYNM Interaction with SYNM Binds to SNTB1 Phosphoserine Phosphoserine Phosphoserine Phosphoserine Phosphoserine Phosphoserine Phosphoserine Phosphoserine Phosphoserine In isoform 3, isoform 4, isoform 5. In isoform 3, isoform 4, isoform 5. In isoform 3. In isoform 5. In isoform 4....

  3. Identification of proteins interacting with extracellularly applied α-syn assemblies, Condition 3 - controls (5/8) OmicsDI

    ID: PXD002260

    Date Released: 09-07-2015

    Description: Fibrillar α-Synuclein (α-Syn) is the principal component of Lewy bodies which are evident in individuals affected by Parkinson disease (PD). This neuropatho...

  4. Identification of proteins interacting with extracellularly applied α-syn assemblies, Condition 4 - controls (7/8) OmicsDI

    ID: PXD002262

    Date Released: 09-07-2015

    Description: Fibrillar α-Synuclein (α-Syn) is the principal component of Lewy bodies which are evident in individuals affected by Parkinson disease (PD). This neuropatho...

  5. Human alphaherpesvirus 1 strain:strain 17 syn+ : Human alphaherpesvirus 1 strain:strain 17 syn+ Transcriptome or Gene expression BioProject

    ID: PRJNA231308

    Keywords: transcriptome

    Access Type: download

  6. Identification of proteins interacting with extracellularly applied α-syn assemblies, Condition 1 - biological replicates (2/8) OmicsDI

    ID: PXD002257

    Date Released: 09-07-2015

    Description: Fibrillar α-Synuclein (α-Syn) is the principal component of Lewy bodies which are evident in individuals affected by Parkinson disease (PD). This neuropatho...

  7. Identification of proteins interacting with extracellularly applied α-syn assemblies, Condition 1 - controls (1/8) OmicsDI

    ID: PXD002256

    Date Released: 09-07-2015

    Description: Fibrillar α-Synuclein (α-Syn) is the principal component of Lewy bodies which are evident in individuals affected by Parkinson disease (PD). This neuropatho...

  8. Identification of proteins interacting with extracellularly applied α-syn assemblies, Condition 2 - biological replicates (4/8) OmicsDI

    ID: PXD002259

    Date Released: 09-07-2015

    Description: Fibrillar α-Synuclein (α-Syn) is the principal component of Lewy bodies which are evident in individuals affected by Parkinson disease (PD). This neuropatho...

  9. Identification of proteins interacting with extracellularly applied α-syn assemblies, Condition 4 - biological replicates (8/8) OmicsDI

    ID: PXD002263

    Date Released: 09-07-2015

    Description: Fibrillar α-Synuclein (α-Syn) is the principal component of Lewy bodies which are evident in individuals affected by Parkinson disease (PD). This neuropatho...

  10. Citalopram connectivity DMN component Figshare

    ID: doi:10.6084/M9.FIGSHARE.4309439

    Release Date: 01-06-2017

    Description: DMN component, identified using ICA.

  11. Citalopram connectivity DMN component Figshare

    ID: doi:10.6084/M9.FIGSHARE.4309439.V3

    Release Date: 01-06-2017

    Description: DMN component, identified using ICA.

  12. Stochastic DCM of the DMN using resting-state fMRI: test-retest reliability Figshare

    ID: doi:10.6084/M9.FIGSHARE.866771.V1

    Release Date: 01-18-2016

    Description:

  13. Identification of proteins interacting with extracellularly applied α-syn assemblies, Condition 3 - biological replicates (6/8) OmicsDI

    ID: PXD002261

    Date Released: 09-07-2015

    Description: Fibrillar α-Synuclein (α-Syn) is the principal component of Lewy bodies which are evident in individuals affected by Parkinson disease (PD). This neuropatho...

  14. Identification of proteins interacting with extracellularly applied α-syn assemblies, Condition 2 - controls (3/8) OmicsDI

    ID: PXD002258

    Date Released: 09-07-2015

    Description: Fibrillar α-Synuclein (α-Syn) is the principal component of Lewy bodies which are evident in individuals affected by Parkinson disease (PD). This neuropatho...

  15. Citalopram connectivity DMN component Figshare

    ID: doi:10.6084/M9.FIGSHARE.4309439.V1

    Release Date: 01-06-2017

    Description: DMN component, identified using ICA.

  16. Citalopram connectivity DMN component Figshare

    ID: doi:10.6084/M9.FIGSHARE.4309439.V2

    Release Date: 01-06-2017

    Description: DMN component, identified using ICA.

  17. Protective effects of Annona muricata ethanolic leaf extract against Dimethylnitrosamine (DMN)-Induced Hepatotoxicity. Figshare

    ID: doi:10.6084/M9.FIGSHARE.1138347

    Release Date: 08-14-2014

    Description:

  18. Stochastic DCM of the DMN using resting-state fMRI: test-retest reliability Figshare

    ID: doi:10.6084/M9.FIGSHARE.866771

    Release Date: 07-04-2014

    Description:

  19. Expression data from Rat liver 48 hours after treated with different toxic compounds ArrayExpress

    ID: E-GEOD-5509

    Description: Rat has been treated with different compounds with the purpose of investigating toxicological mechanisms. But toxic and non-toxic compounds has been a...

  20. Transcription profiling by array of human HepG2 cells after treatment with 2,3-Dimethoxy-1,4-naphthoquinone, N-nitrosodimethylamine, phenol and six he... ArrayExpress

    ID: E-GEOD-6907

    Description: From the results of gene expression analyses of HepG2 under the exposure of 2,3-Dimethoxy-1,4-naphthoquinone (DMNQ), N-nitrosodimethylamine (DMN), phe...


Displaying 20 of 311 results for "SYNM"